Access to early-phase oncology trials: Trajectories and outcomes of more than 26,000 patients referred to a high-volume phase I unit.
Matthieu Roulleaux Dugage
C. Mazza
P. Matte
C. Roussel-Simonin
A. Bayle
A. Hollebecque
K. Ouali
M. Sakkal
A. Gazzah
J. Michot
R. Bahleda
T. Hueso
A. Patrikidou
S. Postel-Vinay
C. Pobel
F. Danlos
V. Ribrag
C. Baldini
I. Borget
Fabrice André
Fabrice Barlési
Y. Loriot
A. Marabelle
C. Massard
Medicine